BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3221827)

  • 1. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
    Motomura Y
    Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nuclear DNA content of thyroid adenocarcinoma].
    Yoshida A
    Nihon Geka Gakkai Zasshi; 1984 Oct; 85(10):1261-73. PubMed ID: 6503946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
    Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
    Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric DNA analysis of papillary carcinoma of the thyroid using paraffin-embedded specimens].
    Yamashita T; Hirayama A; Obara T; Fujimoto Y; Kodama T; Kenmotsu M; Okuda A
    Gan No Rinsho; 1990 Apr; 36(5):569-73. PubMed ID: 2325263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ornithine decarboxylase activity and polyamine levels in human thyroid tumor tissue].
    Yamamoto O
    Nihon Geka Gakkai Zasshi; 1989 Jul; 90(7):1049-56. PubMed ID: 2796972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma.
    Johannessen JV; Sobrinho-Simões M; Tangen KO; Lindmo T
    Lab Invest; 1981 Oct; 45(4):336-41. PubMed ID: 7300245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of flow cytometric DNA determination combined with fine needle aspiration biopsy in thyroid tumors.
    Joensuu H; Klemi PJ; Eerola E
    Anal Quant Cytol Histol; 1987 Aug; 9(4):328-34. PubMed ID: 3663313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric DNA content analysis in thyroid carcinoma].
    Zuo LF
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear DNA pattern of thyroid tumor].
    Tanaka H
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1239-46. PubMed ID: 1403317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nuclear DNA in neoplastic pathology of the thyroid gland].
    Sussi PL; Azzolina LS; Valerio A; Marchioretto F; Brazzarola P; Angeli G; Davì MV; Stival P; Finchi A; Francia G
    Chir Ital; 1994; 46(5):74-6. PubMed ID: 7788816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.
    Joensuu H; Klemi PJ
    Am J Clin Pathol; 1988 Jan; 89(1):35-40. PubMed ID: 3337050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of nuclear DNA content in follicular thyroid tumours.
    Bäckdahl M; Auer G; Forsslund G; Granberg PO; Hamberger B; Lundell G; Löwhagen T; Zetterberg A
    Acta Chir Scand; 1986 Jan; 152():1-7. PubMed ID: 3953203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuclear DNA content in small thyroid papillary carcinomas determined by microfluorometry].
    Omata K; Naoe S; Tanaka N
    Gan No Rinsho; 1987 Feb; 33(2):119-24. PubMed ID: 3560446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA content in radiation-associated thyroid cancer.
    Komorowski RA; Deaconson TF; Vetsch R; Cerletty JM; Wilson SD
    Surgery; 1988 Dec; 104(6):992-6. PubMed ID: 3194850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma.
    Bäckdahl M; Cohn K; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T; Willems JS; Zetterberg A
    Cancer Res; 1985 Jun; 45(6):2890-4. PubMed ID: 3986815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
    Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
    Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.